SS 21 - GU 1: Miscellaneous GU Topics

Moderator(s)

• 

  Krishnan Patel, MD

  National Institutes of Health
  Ellicott City, MD
• 

  Shalini Moningi, MD

  Brigham and Women's Hospital/Dana-Farber
  Boston, MA, United States

Presentations:

• 3:00 PM – 3:10 PM ET

  Renal Function after Definitive Local Therapy for Primary Renal Cell Carcinoma: A Meta-Analysis
  

  Presenter: Nicholas Zaorsky, MD, MS – University Hospitals Case Medical Center
• 3:10 PM – 3:20 PM ET

  Pembrolizumab Monotherapy Following Tri-Modality Treatment for Selected Patients with Muscle-Invasive Bladder Cancer
  

  Presenter: Shang-Bin Qin, MD
• 3:20 PM – 3:30 PM ET

  Exploratory Analyses of Stereotactic Ablative Radiotherapy for Bladder Preservation in Elderly Bladder Cancer Patients: Phase I Results
  

  Presenter: Yun Bai, MD – Peking University First Hospital
• 3:30 PM – 3:40 PM ET

  Bi-Institutional Safety Analysis of Combining Radiotherapy and Enfortumab Vedotin in Advanced Urothelial Cancer
  

  Presenter: Yash Soni, MD, BS – UT Southwestern Medical Center
• 3:40 PM – 3:50 PM ET

  Oncological Outcomes and Toxicities of Brachytherapy for Carcinomas of the Penis: A Bi-Centric Study by the SFRO Brachytherapy Group
  

  Presenter: Kanta Ka, MD, MS – Gustave Roussy Cancer Center
• 3:50 PM – 4:00 PM ET

  Natural History after Likely Cure vs. Recurrence vs. after ProsTate RadiOtheRapy (RAPTOR): A Pooled Analysis of More than 13000 Patients from 21 Randomized Controlled Trials
  

  Presenter: Soumyajit Roy, MS, MBBS – Rush University Medical Center